Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Losses Down, Revenues Up for Q1 of FY2004

NEW YORK, April 27 (GenomeWeb News) - Paradigm Genetics today reported an improved net loss and increased revenues for the first quarter of fiscal year 2004.


The company said it had a net loss of $3.7 million, as compared to $4.1 million for the same quarter last year. Total revenues increased to $4.9 million from $4.1 million during the same quarter last year.


As of March 31, Paradigm had $15.2 million in unrestricted cash, cash equivalents, and short-term investments.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.